3 papers in the library · 112 citations · publishing 2021-2026
PLoS One June 30, 2026 David Sjöström, Olea Schau Rybäck, Emma Claesdotter-Knutsson et al.
Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".
Ketamine 2025 Pouya Movahed Rad, Akihiro Takamiya
Depression is a debilitating psychiatric disorder. Electroconvulsive therapy (ECT) and ketamine are effective treatments for severe depression, but target populations may differ. Systematic reviews on the few available trials show higher remission rates with ECT than with ketamine. Nonetheless, ketamine’s rapid onset of action is comparable to ECT but with less cognitive adverse effects. This...
International Journal of Neuropsychopharmacology December 4, 2021 Joakim Ekstrand, Christian Fattah, Marcus Persson et al. 112 citations
Abstract Background Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression. Methods Hospitalized patients with unipolar depression were randomized (1:1) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel,...